BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 11753991)

  • 1. Expression and prognostic value of epidermal growth factor receptor, transforming growth factor-alpha, and c-erb B-2 in nephroblastoma.
    Ghanem MA; Van Der Kwast TH; Den Hollander JC; Sudaryo MK; Mathoera RB; Van den Heuvel MM; Noordzij MA; Nijman RJ; van Steenbrugge GJ
    Cancer; 2001 Dec; 92(12):3120-9. PubMed ID: 11753991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidermal growth factor family and renal cell carcinoma: expression and prognostic impact.
    Hofmockel G; Riess S; Bassukas ID; Dämmrich J
    Eur Urol; 1997; 31(4):478-84. PubMed ID: 9187911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and prognostic value Of CD44 isoforms in nephroblastoma (Wilms tumor).
    Ghanem MA; Van Steenbrugge GJ; Van Der Kwast TH; Sudaryo MK; Noordzij MA; Nijman RJ
    J Urol; 2002 Aug; 168(2):681-6. PubMed ID: 12131349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-expression of epidermal growth factor receptor and transforming growth factor-alpha predicts worse prognosis in breast-cancer patients.
    Umekita Y; Ohi Y; Sagara Y; Yoshida H
    Int J Cancer; 2000 Nov; 89(6):484-7. PubMed ID: 11102891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and prognostic value of Wilms' tumor 1 and early growth response 1 proteins in nephroblastoma.
    Ghanem MA; Van der Kwast TH; Den Hollander JC; Sudaryo MK; Oomen MH; Noordzij MA; Van den Heuvel MM; Nassef SM; Nijman RM; Van Steenbrugge GJ
    Clin Cancer Res; 2000 Nov; 6(11):4265-71. PubMed ID: 11106242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical studies on oncogene products (EGF-R, c-erbB-2) and growth factors (EGF, TGF-alpha) in human breast cancer: their relationship to oestrogen receptor status, histological grade, mitotic index and nodal status.
    Umekita Y; Enokizono N; Sagara Y; Kuriwaki K; Takasaki T; Yoshida A; Yoshida H
    Virchows Arch A Pathol Anat Histopathol; 1992; 420(4):345-51. PubMed ID: 1348890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demonstration of a TGF-alpha-EGF-receptor autocrine loop and c-myc protein over-expression in papillary thyroid carcinomas.
    Haugen DR; Akslen LA; Varhaug JE; Lillehaug JR
    Int J Cancer; 1993 Aug; 55(1):37-43. PubMed ID: 8102129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth factors and oncogene products in transitional cell carcinoma.
    Nakanishi K; Kawai T; Suzuki M; Torikata C
    Mod Pathol; 1996 Mar; 9(3):292-7. PubMed ID: 8685230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex hormone-induced mammary carcinogenesis in female Noble rats: expression of TGF-beta1 and its receptors, TGF-alpha, and EGF-R in mammary carcinogenesis.
    Xie B; Tsao SW; Wong YC
    Breast Cancer Res Treat; 1999 Dec; 58(3):227-39. PubMed ID: 10718485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concomitant analysis of the epidermal growth factor receptor family in esophageal cancer: overexpression of epidermal growth factor receptor mRNA but not of c-erbB-2 and c-erbB-3.
    Friess H; Fukuda A; Tang WH; Eichenberger A; Furlan N; Zimmermann A; Korc M; Büchler MW
    World J Surg; 1999 Oct; 23(10):1010-8. PubMed ID: 10512940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermal growth factor receptor and transforming growth factor alpha expression in papillary and nonpapillary renal cell carcinoma: correlation with metastatic behavior and prognosis.
    Uhlman DL; Nguyen P; Manivel JC; Zhang G; Hagen K; Fraley E; Aeppli D; Niehans GA
    Clin Cancer Res; 1995 Aug; 1(8):913-20. PubMed ID: 9816062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic significance of apoptosis-associated proteins BCL-2, BAX and BCL-X in clinical nephroblastoma.
    Ghanem MA; Van der Kwast TH; Den Hollander JC; Sudaryo MK; Van den Heuvel MM; Noordzij MA; Nijman RJ; Soliman EH; van Steenbrugge GJ
    Br J Cancer; 2001 Nov; 85(10):1557-63. PubMed ID: 11720445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The predictive value of immunohistochemical markers in untreated Wilms' tumour: are they useful?
    Ghanem MA; van der Kwast TH; Molenaar WM; Safan MA; Nijman RJ; van Steenbrugge GJ
    World J Urol; 2013 Aug; 31(4):811-6. PubMed ID: 21594709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MIB-1 (KI-67) proliferation index and cyclin-dependent kinase inhibitor p27(Kip1) protein expression in nephroblastoma.
    Ghanem MA; Van der Kwast TH; Sudaryo MK; Mathoera RB; van den Heuvel MM; Al-Doray AA; Nijman RM; van Steenbrugge GJ
    Clin Cancer Res; 2004 Jan; 10(2):591-7. PubMed ID: 14760081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of TCF3 as potential master regulator in blastemal Wilms tumors.
    Kehl T; Schneider L; Kattler K; Stöckel D; Wegert J; Gerstner N; Ludwig N; Distler U; Tenzer S; Gessler M; Walter J; Keller A; Graf N; Meese E; Lenhof HP
    Int J Cancer; 2019 Mar; 144(6):1432-1443. PubMed ID: 30155889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of the expression of epidermal growth factor, transforming growth factor alpha, and epidermal growth factor receptor on the prognosis of superficial bladder cancer.
    Türkeri LN; Erton ML; Cevik I; Akdaş A
    Urology; 1998 Apr; 51(4):645-9. PubMed ID: 9586623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between the HER2 expression and histological differentiation in Wilms tumor.
    Salem M; Kinoshita Y; Tajiri T; Souzaki R; Tatsuta K; Higashi M; Izaki T; Kohashi K; Tsuneyoshi M; Taguchi T
    Pediatr Surg Int; 2006 Nov; 22(11):891-6. PubMed ID: 16932912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNA expression of the WT1 gene in Wilms' tumors in relation to histology.
    Miwa H; Tomlinson GE; Timmons CF; Huff V; Cohn SL; Strong LC; Saunders GF
    J Natl Cancer Inst; 1992 Feb; 84(3):181-7. PubMed ID: 1311774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival.
    Rubin Grandis J; Melhem MF; Gooding WE; Day R; Holst VA; Wagener MM; Drenning SD; Tweardy DJ
    J Natl Cancer Inst; 1998 Jun; 90(11):824-32. PubMed ID: 9625170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of p53, transforming growth factor alpha, epidermal growth factor receptor, and c-erbB-2 in endometrial carcinoma and correlation with survival and known predictors of survival.
    Reinartz JJ; George E; Lindgren BR; Niehans GA
    Hum Pathol; 1994 Oct; 25(10):1075-83. PubMed ID: 7927313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.